ZA202007143B - Pyridone derivative, composition thereof and application thereof as anti-influenza drug - Google Patents
Pyridone derivative, composition thereof and application thereof as anti-influenza drugInfo
- Publication number
- ZA202007143B ZA202007143B ZA2020/07143A ZA202007143A ZA202007143B ZA 202007143 B ZA202007143 B ZA 202007143B ZA 2020/07143 A ZA2020/07143 A ZA 2020/07143A ZA 202007143 A ZA202007143 A ZA 202007143A ZA 202007143 B ZA202007143 B ZA 202007143B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- application
- pyridone derivative
- influenza drug
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810044308.4A CN110041327B (zh) | 2018-01-17 | 2018-01-17 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| CN201811517425.4A CN111303147B (zh) | 2018-12-12 | 2018-12-12 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| PCT/CN2019/071902 WO2019141179A1 (zh) | 2018-01-17 | 2019-01-16 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202007143B true ZA202007143B (en) | 2022-04-28 |
Family
ID=67301986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2020/07143A ZA202007143B (en) | 2018-01-17 | 2020-11-16 | Pyridone derivative, composition thereof and application thereof as anti-influenza drug |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11247993B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3753936B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7352297B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102477187B1 (cg-RX-API-DMAC7.html) |
| CN (4) | CN111848615B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019210414B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3088926A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3074017T3 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12020551264A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3753936T (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202011447UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019141179A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202007143B (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| US11286262B2 (en) | 2017-10-06 | 2022-03-29 | Shionogi & Co., Ltd. | Stereoselective process for preparing substituted polycyclic pyridone derivatives |
| HUE069183T2 (hu) * | 2018-02-28 | 2025-02-28 | Novartis Ag | 10-(di(fenil)metil)-4-hidroxi-8,9,9a,10-tetrahidro-7H--pirrolo[1',2':4,5]pirazino[1,2-b]piridazin-3,5-dion származékok és kapcsolódó vegyületek mint orthomyxovírus repikáció gátlók influenza kezelésére |
| WO2020205835A1 (en) * | 2019-04-01 | 2020-10-08 | Nikang Therapeutics, Inc. | Fused polycyclic pyridone compounds as influenza virus replication inhibitors |
| CN111909174B (zh) | 2019-05-08 | 2022-01-21 | 江西彩石医药科技有限公司 | 吡啶酮衍生物的晶型及制备方法和应用 |
| CN112574170A (zh) * | 2019-09-29 | 2021-03-30 | 江西东邦药业有限公司 | 一种二苯并七元环衍生物及其制备方法和应用 |
| CN115135646B (zh) * | 2019-12-23 | 2024-05-17 | 石家庄迪斯凯威医药科技有限公司 | 取代的多环化合物及其药物组合物和用途 |
| CN113045589B (zh) * | 2019-12-27 | 2024-08-23 | 广东东阳光药业股份有限公司 | 流感病毒复制抑制剂及其用途 |
| CN112898346B (zh) * | 2020-01-23 | 2023-11-10 | 南京知和医药科技有限公司 | 水溶性多环化合物及其药物组合物和用途 |
| CN113116899B (zh) * | 2020-03-06 | 2022-12-20 | 广东众生睿创生物科技有限公司 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
| CN111943879A (zh) * | 2020-08-03 | 2020-11-17 | 南通大学 | 一种(3s,4r)3-氨基-4(甲氧基甲基)吡咯烷-1-甲酸叔丁酯及其合成方法 |
| CN120289488A (zh) * | 2020-08-11 | 2025-07-11 | 石家庄迪斯凯威医药科技有限公司 | 多环化合物及其药物组合物和用途 |
| CN115385932A (zh) * | 2021-05-22 | 2022-11-25 | 江西彩石医药科技有限公司 | 吡啶酮衍生物的中间体及其制备方法 |
| CN117003766B (zh) * | 2022-10-08 | 2024-02-02 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒衍生物及其用途 |
| WO2024098856A1 (zh) * | 2022-11-09 | 2024-05-16 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒衍生物及其用途 |
| CN116789556A (zh) * | 2023-05-26 | 2023-09-22 | 康化(上海)新药研发有限公司 | 一种含环丙氧基乙胺的制备方法 |
| WO2026145578A1 (zh) * | 2024-12-30 | 2026-07-09 | 江西科睿药业有限公司 | 固体分散体、药物组合物及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5737691B2 (ja) | 2009-06-15 | 2015-06-17 | 塩野義製薬株式会社 | 置換された多環性カルバモイルピリドン誘導体 |
| LT2620436T (lt) | 2010-09-24 | 2018-08-10 | Shionogi & Co., Ltd. | Pakeistojo policiklinio karbamoilpiridono darinio provaistas |
| CN105764904B (zh) * | 2013-09-12 | 2020-02-11 | 詹森生物制药有限公司 | 氮杂-吡啶酮化合物及其用途 |
| CN107709321A (zh) * | 2015-04-28 | 2018-02-16 | 盐野义制药株式会社 | 经取代的多环性吡啶酮衍生物及其前药 |
| HK1254961A1 (en) * | 2015-12-15 | 2019-08-02 | Shionogi & Co., Ltd. | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| JP6806413B2 (ja) | 2016-02-03 | 2021-01-06 | 塩野義製薬株式会社 | 多環性ピリドン誘導体およびそのプロドラッグ |
| US10759814B2 (en) * | 2016-08-10 | 2020-09-01 | Shionogi & Co., Ltd. | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
-
2019
- 2019-01-16 CN CN202010817434.6A patent/CN111848615B/zh active Active
- 2019-01-16 CN CN201980000078.4A patent/CN110637016B/zh active Active
- 2019-01-16 EP EP19741336.2A patent/EP3753936B1/en active Active
- 2019-01-16 CN CN202010817435.0A patent/CN111848616B/zh active Active
- 2019-01-16 CA CA3088926A patent/CA3088926A1/en active Pending
- 2019-01-16 CN CN202010817035.XA patent/CN111848614B/zh active Active
- 2019-01-16 US US16/487,088 patent/US11247993B2/en active Active
- 2019-01-16 SG SG11202011447UA patent/SG11202011447UA/en unknown
- 2019-01-16 PT PT197413362T patent/PT3753936T/pt unknown
- 2019-01-16 ES ES19741336T patent/ES3074017T3/es active Active
- 2019-01-16 AU AU2019210414A patent/AU2019210414B2/en active Active
- 2019-01-16 KR KR1020207023803A patent/KR102477187B1/ko active Active
- 2019-01-16 JP JP2020560532A patent/JP7352297B2/ja active Active
- 2019-01-16 WO PCT/CN2019/071902 patent/WO2019141179A1/zh not_active Ceased
-
2020
- 2020-08-17 PH PH12020551264A patent/PH12020551264A1/en unknown
- 2020-11-16 ZA ZA2020/07143A patent/ZA202007143B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102477187B1 (ko) | 2022-12-12 |
| AU2019210414A1 (en) | 2020-09-03 |
| SG11202011447UA (en) | 2020-12-30 |
| CA3088926A1 (en) | 2019-07-25 |
| ES3074017T3 (en) | 2026-07-16 |
| PT3753936T (pt) | 2026-07-10 |
| CN111848616A (zh) | 2020-10-30 |
| WO2019141179A1 (zh) | 2019-07-25 |
| CN110637016A (zh) | 2019-12-31 |
| CN111848615A (zh) | 2020-10-30 |
| CN110637016B (zh) | 2020-08-18 |
| US20190367517A1 (en) | 2019-12-05 |
| EP3753936A1 (en) | 2020-12-23 |
| US11247993B2 (en) | 2022-02-15 |
| EP3753936B1 (en) | 2026-04-08 |
| KR20200118062A (ko) | 2020-10-14 |
| CN111848616B (zh) | 2021-11-23 |
| CN111848615B (zh) | 2022-05-17 |
| JP7352297B2 (ja) | 2023-09-28 |
| EP3753936A4 (en) | 2022-03-23 |
| CN111848614A (zh) | 2020-10-30 |
| CN111848614B (zh) | 2021-11-23 |
| JP2021511374A (ja) | 2021-05-06 |
| PH12020551264A1 (en) | 2021-05-31 |
| AU2019210414B2 (en) | 2021-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202011447UA (en) | Pyridone derivative, composition and use as antiviral drug thereof | |
| ZA201900470B (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| IL307911B1 (en) | Heterocyclic derivatives, pharmaceutical compositions comprising thereof, and their uses as medicaments | |
| SG11202005962YA (en) | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application | |
| PL3590924T3 (pl) | Nowa pochodna izoindoliny oraz jej kompozycja farmaceutyczna i zastosowanie | |
| EP3539963A4 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | |
| SI3453707T1 (sl) | Benzazepinski derivati, postopek priprave, farmacevtski sestavek in uporaba le-teh | |
| ZA201906451B (en) | 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same | |
| HUE057289T2 (hu) | Oxopikolinamid-származék, annak elõállítási módszere és gyógyszerészeti felhasználása | |
| CA3273336A1 (en) | Glucagon derivative and a composition comprising a long acting conjugate of the same | |
| EP3214081A4 (en) | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof | |
| EP3357513A4 (en) | Pharmaceutical composition and application thereof | |
| PT3580208T (pt) | Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro | |
| ZA201804692B (en) | Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications | |
| EP3159338A4 (en) | Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient | |
| GB2572305B (en) | Heterocyclic urea compound, and drug composition and application thereof | |
| IL251780B (en) | Derivatives of 5-(3-hydroxy-propyn-1-yl)-3-(2-amino-pyrimidinyl)-h1-pyrrolo[c-3,2] pyridine and pharmaceutical preparations containing them | |
| EP3255042A4 (en) | Heterocyclic compound and pharmaceutical composition comprising same | |
| IL272638A (en) | History of quinoxaline, their preparation and pharmaceutical preparations containing them | |
| EP3181553A4 (en) | Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof | |
| EP3381925A4 (en) | Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof | |
| IL262929B1 (en) | Preparations for treatment, methods of their preparation and their uses | |
| EP3103453A4 (en) | Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
| EP3124486A4 (en) | Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof | |
| SG11202002422WA (en) | Novel phenylpyridine derivative and pharmaceutical composition comprising the same |